Beaird Harris Wealth Management’s ARK Genomic Revolution ETF ARKG Stock Holding History

Beaird Harris Wealth Management’s Portfolio ARKG Stock Details ARKG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-4	Closed	-$94	–	525
2024 Q2	$94	Hold	4	–	–	﹤0.01%	663
2024 Q1	$116	Hold	4	–	–	﹤0.01%	615
2023 Q4	$132	Hold	4	–	–	﹤0.01%	593
2023 Q3	$112	Hold	4	–	–	﹤0.01%	435
2023 Q2	$137	Sell	4 -38	-90%	-$1.19K	﹤0.01%	442
2023 Q1	$1.26K	Hold	42	–	–	﹤0.01%	401
2022 Q4	$1.19K	Hold	42	–	–	﹤0.01%	630
2022 Q3	$1K	Buy	42 +4	+11%	+$147	﹤0.01%	422
2022 Q2	$1K	Hold	38	–	–	﹤0.01%	362
2022 Q1	$2K	Hold	38	–	–	﹤0.01%	511
2021 Q4	$2K	Buy	+38	New	+$2.63K	﹤0.01%	557

Other funds holding ARKG

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

MMEA

Main Management ETF Advisors San Francisco, California $2.68B AUM 24.27% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Beaird Harris Wealth Management's ARKG Position: Q3 2024 in Review

Beaird Harris Wealth Management sold out of ARK Genomic Revolution ETF (ARKG) in Q3 2024, closing a stake of 4 shares — an estimated $94 sold.

Beaird Harris Wealth Management first reported a position in ARKG in Q4 2021 and held it in 11 quarters. The position peaked at $2K in Q1 2022. 238 funds tracked by Wall St. Rank hold ARKG as of Q3 2024.

Beaird Harris Wealth Management reported no remaining ARK Genomic Revolution ETF position as of Q3 2024 after selling out during the quarter.
Beaird Harris Wealth Management sold 4 ARK Genomic Revolution ETF shares in Q3 2024, an estimated $94.
Beaird Harris Wealth Management first reported a position in ARK Genomic Revolution ETF in Q4 2021 and held it in 11 quarters.
Beaird Harris Wealth Management's ARK Genomic Revolution ETF position peaked at $2K in Q1 2022.
238 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q3 2024.

Based on Beaird Harris Wealth Management's 13F filing for Q3 2024, filed 2 Dec 2024.